10 months ago
SDGR
AnalystsDo KimDo Kim's Stock Forecasts
AnalystsDo Kim
Analyst Ranking
Bottom 10%
#4017 out of 4414 analysts
Average Return
-5.17%
Win Rate
40%27 out of 68
Risk vs Reward
Poor
Good
Do Kim's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Schrodinger IncSDGR | +138.50% | $44.75 | $106.73 | 2020-03-01 - 2021-03-02 | Buy |
Halozyme Therapeutics IncHALO | +126.34% | $19.25 | $43.57 | 2020-01-08 - 2021-01-08 | Buy |
Alnylam Pharmaceuticals IncALNY | +93.03% | $50.95 | $98.35 | 2017-04-16 - 2018-04-17 | Buy |
Akcea Therapeutics IncAKCA | +87.20% | $16.80 | $31.45 | 2018-02-26 - 2019-02-27 | Buy |
Affimed NvAFMD | +83.75% | $1.60 | $2.94 | 2018-08-08 - 2019-08-09 | Buy |
Do Kim Analyst Color
Get additional color on Do Kim's coverage of popular stocks
10 months ago
CDXS
a year ago
TVTX
Do Kim's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 11 | Strong Buy | $58.00 | +17.39% | Assumes | 6 months ago |
Travere Therapeutics IncTVTX | 6 | Strong Buy | $46.00 | +619.87% | Maintains | 9 months ago |
Vertex Pharmaceuticals IncVRTX | 11 | Hold | $296.00 | -15.67% | Maintains | 10 months ago |
Gilead Sciences IncGILD | 7 | Strong Buy | $112.00 | +48.88% | Maintains | 10 months ago |
Schrodinger IncSDGR | 4 | Strong Buy | $87.00 | +176.54% | Maintains | 10 months ago |
Codexis IncCDXS | 2 | Strong Buy | $23.00 | +846.50% | Maintains | 10 months ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $10.00 | +575.68% | Maintains | a year ago |
Affimed NvAFMD | 4 | Strong Buy | $6.00 | +1,053.85% | Maintains | a year ago |
Rigel Pharmaceuticals IncRIGL | 3 | Hold | $2.00 | N/A | Maintains | a year ago |
Replimune Group IncREPL | 2 | Strong Buy | $43.00 | N/A | Maintains | a year ago |
Exelixis IncEXEL | 1 | Strong Buy | $32.00 | N/A | Maintains | a year ago |
Abcellera Biologics IncABCL | 4 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Morphic Holding IncMORF | 1 | Buy | $102.00 | N/A | Maintains | 3 years ago |
Nuvation Bio IncNUVB | 1 | Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 10 | Hold | $185.00 | N/A | Downgrades | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Buy | $50.00 | N/A | Upgrades | 3 years ago |
Exicure IncXCUR | 1 | Buy | $180.00 | N/A | Initiates Coverage On | 3 years ago |
Akcea Therapeutics IncAKCA | 4 | Hold | $18.15 | N/A | Downgrades | 3 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Obseva SaOBSVF | 1 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Halozyme Therapeutics IncHALO | 6 | Buy | $24.00 | N/A | Upgrades | 4 years ago |
Vbi Vaccines IncVBIV | 2 | Buy | $360.00 | N/A | Maintains | 5 years ago |
Fate Therapeutics IncFATE | 1 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.